
Ronyglim MP 1mg/500mg/15mg Tablet
Marketer
Ronyd Healthcare Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Ronyglim MP 1mg/500mg/15mg Tablet
Glucotrim Trio 1mg/500mg/15mg tablets offer triple-action blood sugar management. This formulation, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, thus reducing blood glucose. Dosage and frequency for Glucotrim Trio should strictly adhere to your physician's instructions. Always take it with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly, unless nearing the next scheduled dose; in this case, omit the missed dose and resume the regular regimen. Never double the dose. Excessive intake can trigger hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; diligent blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Renal function tests will be conducted before treatment begins. Limit alcohol consumption to mitigate potential adverse reactions.
Uses of Ronyglim MP 1mg/500mg/15mg Tablet
Managing Type 2 Diabetes
Major Benefits of Ronyglim MP 1mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the Ronyglim MP 1mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.
Common Side effects of Ronyglim MP 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Ronyglim MP 1mg/500mg/15mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Ronyglim MP 1mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing. Consume with food.
How Ronyglim MP 1mg/500mg/15mg Tablet works:
Ronyglim MP tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to enhance blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Ronyglim MP 1mg/500mg/15mg Tablet with alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
The use of Ronyglim MP 1mg/500mg/15mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Maternal use of Ronyglim MP 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Ronyglim MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. For patients exhibiting severe kidney disease, this medication is contraindicated. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Ronyglim MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Ronyglim MP 1mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Ronyglim MP 1mg/500mg/15mg Tablet :
Should you forget a dose of Ronyglim MP 1mg/500mg/15mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ronyglim MP 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
